AzTrials
AzTrials

Chronic Low Back PainNCT07141082

Expressive Art Therapy for Elder Adults With Chronic Low Back Pain

A study testing Art therapy combined with Exercise and Exercise in people with Chronic Low Back Pain, run by The Hong Kong Polytechnic University at 1 site in Hong Kong.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This research project aims to assess the feasibility of expressive art therapy for elderly adults with chronic low back pain and to evaluate the preliminary efficacy of combining art therapy with exercise intervention. Additionally, the study will investigate facilitators and barriers to participation. Read more about this study

Who is it for?
Ages 60 years and older
Conditions the study is for
Chronic Low Back Pain
What is being tested?
Art therapy combined with Exercise and Exercise
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteHong Kong
Study dates
2 Aug 2025to 1 Dec 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 60 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • aged 60 years and above
  • currently experiencing non-specific low back pain for at least three months
  • who have sought medical treatment for CLBP
  • can read and write in Traditional Chinese
  • MoCA-5 of 18 or above

Who cannot join

  • malignant pain
  • lumbar spinal stenosis
  • confirmed dementia
  • severe cognitive impairment
  • serious major medical or psychiatric disorders
  • currently receiving physiotherapy, cognitive therapy, or psychological treatments

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Fadi Al Zoubi, PhD contact

852-2766-6705

fadi.alzoubi@polyu.edu.hk

Hong Kong1 site, 1 recruiting
  • Department of Rehabilitation Sciences, The Hong Kong Polytechnic University

    Hong Kong

    Fadi MQ Al Zoubi, PhD, 852 2766 6705, fadi.alzoubi@polyu.edu.hk

    Fadi MQ Al Zoubi, PhD

    Recruiting

Other trials in Hong Kong

About this study

Official title: A Pilot Randomized Controlled Trial Exploring the Use of Supervised Group Art Therapy Among Older Adults With Chronic Low Back Pain: Feasibility, Potential Efficacy, and Participant Experiences

This research project aims to assess the feasibility of expressive art therapy for elderly adults with chronic low back pain and to evaluate the preliminary efficacy of combining art therapy with exercise intervention. Additionally, the study will investigate facilitators and barriers to participation.

A mixed-methods approach will be employed, including a quantitative questionnaire and qualitative semi-structured focus group discussions. The questionnaire will examine physical, functional, and psychological changes potentially influenced by art therapy, while the focus groups will provide in-depth insights into participants' experiences and perceptions of the combined intervention.

Read the detailed description

Chronic low back pain (CLBP) is a common and debilitating condition that affects millions of older adults worldwide, significantly impacting their physical, emotional, and social well-being. This pilot randomized controlled trial (RCT) aims to explore the feasibility and potential effectiveness of a new approach that combines supervised group expressive art therapy with exercise for elderly individuals suffering from CLBP.

The primary goal is to assess participant recruitment, retention, and adherence to intervention. The investigators will also identify any logistical challenges that may arise during the process. To gather preliminary data on the intervention's effectiveness, the investigators will measure changes in pain intensity, functional ability, psychological flexibility, and health-related quality of life (HRQoL).

In addition to quantitative measures, the investigators will conduct qualitative interviews and focus groups to gain deeper insights into the participants' experiences. This will help to identify factors that facilitate or hinder their engagement with the program.

By incorporating expressive art therapy-an approach that encourages emotional expression and coping strategies-this study aims to provide a holistic method for managing pain. The ultimate goal is to enhance the quality of life for older adults affected by CLBP. If successful, this pilot RCT will offer valuable insights that could inform a larger, definitive RCT, paving the way for innovative, interdisciplinary strategies in chronic pain management and improving health outcomes in the community.

Being tested
Art therapy combined with Exercise, Exercise
Keywords
art therapy, expressive art, chronic low back pain, Musculoskeletal Diseases, physiotherapy practice, Physical therapists, Physiotherapists
Medical subject headings
Musculoskeletal Diseases

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Art therapy combined with ExerciseOther

    The intervention program consists of one hour of expressive art intervention followed by one hour of exercise training. Art therapy sessions will be conducted in small groups of eight participants, facilitated by a part-time registered expressive art therapist. Each session begins with a 5-minute introduction and check-in, welcoming participants and encouraging them to share their current status. This is followed by a 10-minute mindfulness exercise designed to center participants and promote relaxation, preparing them for the creative activities ahead. The core of each session features a 20-minute art-making process focused on specific themes that guide participants in exploring their pain and personal narratives.

  • ExerciseOther

    each one-hour session in the exercise control group will involve progressive back and general reconditioning exercises, along with back care education to support self-management of LBP.

Study groups in NCT07141082
Study groupRoleWhat they receive
Experimental: Expressive art therapyExperimentalOne hour of expressive art therapy followed by exercise session.
Receives: Other: Exercise
Control Group: ExerciseActive comparatorThe control group will be a one-hour session that includes progressive back strengthening and general reconditioning exercises, complemented by education on back care to support self-management of low back pain.
Receives: Other: Art therapy combined with Exercise

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Recruitment rate

    The proportion of eligible participants who agree to enrol in the study.

    Measured: Baseline

  2. Retention Rate of participants

    The proportion of participants who complete the full study protocol.

    Measured: Through study completion, an average of 8 weeks

  3. Proportion of Participants Adhering to Intervention

    Intervention adherence will be assessed by the proportion of participants who attended at least 80% of the scheduled group sessions out of the total number randomized. Reasons for non-adherence will be explored through qualitative interviews with participants who did not meet the attendance threshold or discontinued the program prematurely.

    Measured: Weekly from week 1 through 8

  4. Acceptability of the Intervention-satisfaction

    Participants will rate their satisfaction with the program on a scale from 0 (not satisfied) to 10 (very satisfied).

    Measured: Weekly from week 1 through 8

  5. Acceptability of the Intervention-perceived burden

    Participants will rate the perceived burden of the intervention on a scale from 0 (not demanding) to 10 (very demanding).

    Measured: Weekly from week 1 through 8

  6. Acceptability of the Intervention-willingness to continue

    Participants will rate their willingness to continue with the program on a scale from 0 (not willing to continue) to 10 (very willing to continue).

    Measured: Weekly from week 1 through 8

  7. Feasibility of data collection procedures

    This outcome measure will evaluate the feasibility and acceptability of the data collection methods used in the study, including completion rates for outcome assessments.

    Feasibility Metrics:

    Completion Rates for Outcome Assessments: The number of completed assessments will be divided by the total number of scheduled assessments to calculate the completion rate.

    Measured: At 3-month post intervention

  8. Safety and Adverse Events of participants

    This outcome measure will document any adverse events or safety concerns that arise during the study, including:

    Undesirable medical occurrences or problems that a participant experiences during or after the intervention, lasting more than 2 days and/or causing the participant to seek additional treatment.

    These adverse events will be categorized into:

    Serious Related Adverse Events Non-Serious Adverse Events

    Safety Metrics:

    Number and type of adverse events Proportion of participants who report serious related adverse events Proportion of participants who report non-serious adverse events

    Measured: Weekly from week 1 through 8

Secondary outcomes (6)
  1. Global Impression of Change scale

    This is a complementary measure allows patients to self-report their impression of the overall change in their condition from the beginning of a study or intervention to the current time point. This provides a global, subjective evaluation of the patient's perceived improvement or worsening of their symptoms or health status. This item has a 7-point rating, with the following response options: very much improved, much improved, minimally improved, no change, minimally worse, much worse, and very much worse.

    Measured: Immediately post-intervention and at the 3-month follow-up post-intervention

  2. Numeric Pain Rating Scale (NPRS)

    An 11-point scale measuring low back pain intensity, where 0 indicates no pain and 10 indicates the worst imaginable pain. Participants need to report their back pain in the current moment, in the last 24 hours and the last 3 months.

    Measured: Baseline, immediately post-intervention, and 3 month follow up post-intervention

  3. Acceptance and Action Questionnaire II (AAQ-II)

    This 7-item Chinese version measures participants' psychological flexibility, rated on a 7-point scale, where higher scores indicate less flexibility.

    AAQ-II has been cross-culturally adapted and validated among local adolescents and has demonstrated satisfactory internal consistency and test-retest reliability

    Measured: Baseline, immediately post-intervention, and 3 month follow up post-intervention

  4. EQ-5D-5L

    The Chinese version of this instrument measures HRQoL across five domains, providing insight into participants' overall well-being.It comprises 5 items related to mobility, self-care, daily activities, pain/discomfort, and anxiety/depression. Each item has 5 response options (no problem', 'slight problems', 'moderate problems', 'severe problems', and 'extreme problems/unable to').

    It has been found to useful in monitoring treatments' effects on HRQoL.

    Measured: Baseline, immediately post-intervention, and 3 month follow up post-intervention

  5. Roland Morris Disability Index (RMDQ)

    The 24-item Chinese version of the Roland-Morris Disability Questionnaire assesses disability related to low back pain (LBP) in individuals with chronic low back pain (CLBP). Scores range from 0 to 24, with higher scores indicating greater functional limitation and worse disability.

    Measured: Baseline, immediately post-intervention, and 3 month follow up post-intervention

  6. Depression, Anxiety, and Stress Scales (DASS)

    The 21-item Chinese version evaluates mental health across three domains, with higher scores indicating greater issues. It has been cross-culturally adapted to Hong Kong settings,demonstrating excellent internal consistency for depression, anxiety, and stress subscales.

    Measured: Baseline, immediately post-intervention, and 3 month follow up post-intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Aug 2025
  2. Study start2 Aug 2025
  3. Primary completion1 Dec 2026 (estimated)
  4. Study completion1 Dec 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Eligible participants will be randomized using cluster randomization, allocating them into two groups: the expressive art therapy plus exercises group or the exercise-only group. A research assistant not involved in the study will manage allocation. Randomization will stratify participants based on sex and functional level to ensure balanced representation in both groups.
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07141082
Sponsor's protocol ID
HSEARS20250416004-01
Other IDs
1-WZBS
Status last verified
Sep 2025
First submitted
6 Aug 2025
Last updated
8 Sep 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: All personal data will be anonymized. The investigators will minimize the use of personal data in the study as much as possible. The data will be kept for 5 years after project completion, with limited access by Dr. Fadi Al Zoubi.

Questions about this trial

What is this clinical trial studying?

A study testing Art therapy combined with Exercise and Exercise in people with Chronic Low Back Pain, run by The Hong Kong Polytechnic University at 1 site in Hong Kong.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 8 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Hong Kong. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Fadi Al Zoubi, PhD (852-2766-6705, fadi.alzoubi@polyu.edu.hk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Recruitment rate (time frame: Baseline). The study lists 8 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Sep 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in